Dallah Healthcare Company 4004.SR · Stock Open Dallah Healthcare Company in new tab
Dallah Healthcare Company Analysis (4004.SR)
Is Dallah Healthcare Company a good investment? Dallah Healthcare Company (4004.SR) is currently trading at 75.30 SAR. Market analysts have a consensus price target of 106.55 SAR. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 21.14. This valuation is generally in line with the broader market.
Earnings Schedule: Dallah Healthcare Company is expected to release its next earnings report on Nov. 9, 2026. The market consensus estimate for Forward EPS is 5.12.
For income investors, Dallah Healthcare Company pays a dividend yield of 2.04%. With a payout ratio of 45%, the dividend appears sustainable.
Investor FAQ
Does Dallah Healthcare Company pay a dividend?
Yes, it pays an annual dividend of 1.67 SAR (2.04% yield).
What asset class is Dallah Healthcare Company?
Dallah Healthcare Company is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Nov. 9, 2026. The company currently has a trailing EPS of 3.61.
Company Profile
Dallah Healthcare Company operates as a health care company in the Kingdom of Saudi Arabia. The company engages in operating, managing, equipping, and developing hospitals and healthcare facilities, medical centres, complexes, and clinics; and the provision of manpower and support services. It also offers pharmaceuticals, cosmetics, consumables, equipment, and nutritional supplements, as well as medications, diagnostics, and medical technologies. In addition, the company provides personalized treatment plans, post-surgical recovery and chronic condition management, in-home nursing and physiotherapy, and teleconsultations and remote monitoring services. Further, it manages private hospitals, medical and diagnostic centers, and an analytical laboratory; and provides medical services. The company was formerly known as Dallah Healthcare Holding Company and changed its name to Dallah Healthcare Company in November 2016. The company was founded in 1987 and is based in Riyadh, Saudi Arabia.
| Year | Total Dividends |
|---|---|
| ▸2027 |
1.50 SAR
|
| Aug. 16, 2027 (estimated) | 0.5000 |
| June 8, 2027 (estimated) | 0.5000 |
| April 7, 2027 (estimated) | 0.5000 |
| ▸2026 |
2.00 SAR
|
| Nov. 30, 2026 (estimated) | 0.5000 |
| Aug. 27, 2026 | 0.5000 |
| June 4, 2026 | 0.5000 |
| April 7, 2026 | 0.5000 |
| ▸2025 |
2.00 SAR
|
| Nov. 30, 2025 | 0.5000 |
| Sept. 4, 2025 | 0.5000 |
| June 29, 2025 | 0.5000 |
| April 20, 2025 | 0.5000 |
| ▸2024 |
2.00 SAR
|
| Dec. 1, 2024 | 0.5000 |
| Sept. 8, 2024 | 0.5000 |
| Aug. 14, 2024 | 0.5000 |
| Jan. 30, 2024 | 0.5000 |
| ▸2023 |
1.50 SAR
|
| Nov. 26, 2023 | 0.5000 |
| Sept. 7, 2023 | 0.5000 |
| July 20, 2023 | 0.5000 |
| ▸2022 |
2.00 SAR
|
| Dec. 29, 2022 | 1.0000 |
| Oct. 9, 2022 | 1.0000 |
| ▸2021 |
1.75 SAR
|
| Dec. 30, 2021 | 1.0000 |
| Oct. 14, 2021 | 0.5000 |
| April 11, 2021 | 0.2500 |
| ▸2020 |
1.20 SAR
|
| Dec. 28, 2020 | 0.5000 |
| April 5, 2020 | 0.7000 |
| ▸2019 |
2.00 SAR
|
| Dec. 5, 2019 | 0.5000 |
| Jan. 6, 2019 | 1.5000 |
| ▸2018 |
2.50 SAR
|
| June 11, 2018 | 2.5000 |
| ▸2017 |
3.64 SAR
|
| Dec. 14, 2017 | 1.6389 |
| May 8, 2017 | 2.0000 |
| ▸2016 |
1.50 SAR
|
| May 31, 2016 | 1.5000 |
| ▸2015 |
1.00 SAR
|
| June 8, 2015 | 1.0000 |
| ▸2014 |
1.50 SAR
|
| June 1, 2014 | 1.5000 |
| ▸2013 |
1.50 SAR
|
| May 18, 2013 | 1.5000 |
| Name | Payment Date | Status | Amount |
|---|---|---|---|
| Dallah Healthcare Company | Aug 27, 2026 | Paid | 0.5 SAR |
| Dallah Healthcare Company | Jun 04, 2026 | Paid | 0.5 SAR |
| Dallah Healthcare Company | Apr 07, 2026 | Paid | 0.5 SAR |
| Dallah Healthcare Company | Nov 30, 2025 | Paid | 0.5 SAR |
Community Discussion